Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Counterpoint: the case for immediate active treatment.

Stacy Loeb1, William J Catalona

  • 1Department of Urology, Georgetown University School of Medicine, Washington, DC, USA.

Journal of the National Comprehensive Cancer Network : JNCCN
|August 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Telehealth Utilization for Prostate Cancer Management in the Veteran Affairs Healthcare System: A Study from 2016 to 2023.

Journal of general internal medicine·2026
Same author

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

European urology·2026
Same author

Availability, quality, and understandability of English and Spanish-language YouTube content on PSMA PET imaging for prostate cancer.

Clinical imaging·2026
Same author

Balancing Cure and Quality of Life: Navigating Functional Outcomes in Localized Prostate Cancer.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same author

The burden of Peyronie's disease on the female partner: a qualitative study.

The journal of sexual medicine·2026
Same author

Intimacy After Diagnosis: Navigating Sexual Health Conversations and Disparities Among Cancer Survivors.

The American journal of hospice & palliative care·2026

Active monitoring for low-risk prostate cancer is gaining attention. However, current criteria lack sufficient predictive power for treatment outcomes in men with long life expectancies.

Area of Science:

  • Urology
  • Oncology

Background:

  • Active monitoring is a potential strategy for men with low-risk prostate cancer and a life expectancy over 10 years.
  • Current criteria do not adequately predict outcomes for individuals with localized disease undergoing immediate, delayed, or no treatment.

Discussion:

  • This article reviews evidence on treatment outcomes for low-risk prostate cancer.
  • It argues for the benefits of immediate active treatment in select cases.

Key Insights:

  • Lack of predictive criteria for low-risk prostate cancer outcomes.
  • Need for better methods to guide treatment decisions.

Outlook:

  • Further research is needed to refine prognostic criteria.
  • Optimizing treatment strategies for long-term survival in prostate cancer patients.

Related Experiment Videos